Skip to content

The effect of superfood (NBS) on depression, anxiety, stress and weight

Evaluating the effects of the supplement supper food (NBS) on depression, anxiety, stress and weight in women with depression and overweight (or obesity) compared to control group

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140203016465N7
Enrollment
50
Registered
2021-01-29
Start date
2020-04-08
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Mild Depression. Condition 2: moderate depression. Condition 3: obesity. Major depressive disorder, single episode, mild Major depressive disorder, single episode, moderate Obesity due to excess calories

Interventions

Intervention 1: Intervention group: daily, 5 grams of wheat germ powder supplement (produced by Super Food NBS). Intervention 2: Control group: 5 grams placebo of wheat germ powder (produced by Super

Sponsors

Tehran University of Medical Sciences
Lead Sponsor
NBS Company
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age 18 to 50 years overweight or obesity diagnosis of depression based on DSM-5 criteria signing of the consent form

Exclusion criteria

Exclusion criteria: People taking antidepressants. Also severe depression, psychotic depression or suicidal ideation Taking glucocorticoids and steroidal anti-inflammatory drugs People who take medicine to reduce appetite or weight People with diabetes who are taking medication or insulin People with heart disease or hypercholesterolemia who take drugs (stein, fibrates, diuretics) Contraceptive hormones Pregnancy and lactation Menopause Severe mental disorders, bipolar and schizophrenia and ... Hypothyroidism

Design outcomes

Primary

MeasureTime frame
Depression score in depression anxiety stress scale-21 (DASS-21) questionnaire. Timepoint: Baseline, week 4, and week 8. Method of measurement: depression anxiety stress scale-21 (DASS-21) questionnaire.;Weight. Timepoint: Baseline, week 4, and week 8. Method of measurement: Standard scales.

Secondary

MeasureTime frame
Anxiety scored by depression anxiety stress scale (DASS-21). Timepoint: at baseline, week 4, and week 8. Method of measurement: Depression anxiety stress scale (DASS-21).;Stress score by depression anxiety stress scale (DASS-21). Timepoint: at baseline, week 4, and week 8. Method of measurement: Depression anxiety stress scale (DASS-21).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed-Ali Mostafavi

Tehran University of Medical Sciences

mostafavi_a@sina.tums.ac.ir+98 21 5542 1959

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026